Clinical Trials Browser

Sarcoma × Erlotinib Hydrochloride × Clear all

NCT00068367 2017-11-06

S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor

Phase 2 Completed

24 enrolled 7 charts

Sarcoma, Neurofibrosarcoma

NCT00603356 2011-09-27

Phase I Study of OSI-930 and Erlotinib in Cancer Tumors

Phase 1 Completed

GastrointestinalGynecologicOther solid neoplasmSarcomaThoracic

Mesothelioma, Neoplasms, Ovarian Neoplasms, Sarcoma, Colorectal Neoplasms